<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04566367</url>
  </required_header>
  <id_info>
    <org_study_id>JWGUHMED1-011</org_study_id>
    <nct_id>NCT04566367</nct_id>
  </id_info>
  <brief_title>Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer</brief_title>
  <official_title>Detection Rate by Blue Laser Imaging (BLI) of Secondary or Early Squamous Head and Neck Cancer in Patients Undergoing Elective Percutaneous Endoscopic Gastrostomy (PEG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georg Dultz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study wants to focus on Carcinoma detection rates with blue laser imaging (BLI) for&#xD;
      participants with head-neck cancer who need a percutaneous endoscopic gastrostomy (PEG). BLI&#xD;
      is a new imaging technique that can easily be used within a standard gastroscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Head-Neck cancers are a significant burden all around the world. Patients suffering from one&#xD;
      tumor are at high risk for a second cancer or another precancerous lesion. Before or during&#xD;
      cancer treatment a PEG is needed to maintain a sufficient calories intake. PEG is established&#xD;
      by performing a standard gastroscopy.&#xD;
&#xD;
      This randomised study wants to compare the detection rates of standard white light endoscopy&#xD;
      compared to the additional use of blue laser imaging for second cancers or precancerous&#xD;
      lesions in participants presenting for PEG establishment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 22, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 22, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This study is a prospective randomised mono centric study with a one to one allocation in two different treatment arms.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The participants don't know which arm they were allocated to.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Detection rate of a second cancer or precancerous lesions</measure>
    <time_frame>The time frame is during the PEG insertion (approximately 15min)</time_frame>
    <description>The detection rates for malignant or premalignant lesions in participants with head neck tumors will be compared when using BLI and white light endoscopy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Head Neck Cancer</condition>
  <condition>Esophageal Cancer</condition>
  <condition>Gastrostomy</condition>
  <arm_group>
    <arm_group_label>Standard White Light Imaging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group the participants will be examined by white light endoscopy first and secondly with blue laser imaging technique during the same gastroscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blue Light Imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group the participants will be examined by blue laser imaging technique first and secondly with standard white light during the same gastroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blue laser imaging</intervention_name>
    <description>The intervention is the push on demand activation of blue laser imaging technique during gastroscopy.</description>
    <arm_group_label>Blue Light Imaging</arm_group_label>
    <arm_group_label>Standard White Light Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All participants with the need of PEG due to head neck cancers or esophageal carcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minors, pregnant women, contraindication for endoscopy, contraindications for&#xD;
             establishment of a PEG&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mireen Friedrich-Rust, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Frankfurt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mireen Friedrich-Rust, Professor</last_name>
    <phone>06963015333</phone>
    <email>mireen.friedrich-rust@kgu.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christiana Graf, MD</last_name>
    <phone>06963015333</phone>
    <email>christiana.graf@kgu.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum der J. W. Goethe-Universit√§t</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mireen Friedrich-Rust, MD</last_name>
      <email>Mireen.Friedrich-Rust@kgu.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 2, 2018</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>September 22, 2020</last_update_submitted>
  <last_update_submitted_qc>September 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Georg Dultz</investigator_full_name>
    <investigator_title>Record Keeper</investigator_title>
  </responsible_party>
  <keyword>esophageal cancer</keyword>
  <keyword>Blue laser imaging</keyword>
  <keyword>percutaneous endoscopic gastrostomy</keyword>
  <keyword>head neck cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

